Cotazym and Haematocele - a phase IV clinical study of FDA data
We study 334 people who take Cotazym or have Haematocele. No report of Haematocele is found in people who take Cotazym.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Cotazym?
Cotazym has active ingredients of pancrelipase (amylase;lipase;protease). eHealthMe is studying from 328 Cotazym users for its effectiveness, alternative drugs and more.
What is Haematocele?
Haematocele (collection of blood in a body cavity) is found to be associated with 15 drugs by eHealthMe.
Do you take Cotazym and have Haematocele?Check whether Haematocele is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Haematocele and when was it recovered:
Expand to all the drugs that have ingredients of pancrelipase (amylase;lipase;protease):
Alternative drugs to, pros and cons of Cotazym:
- Cotazym (328 reports)
Haematocele treatments and more:
- Haematocele (6 reports)
COVID vaccines that are related to Haematocele:
- Haematocele in Moderna COVID Vaccine
- Haematocele in Pfizer BioNTech Covid Vaccine
- Haematocele in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Haematocele:
All the conditions that are associated with Haematocele:
How the study uses the data?
The study uses data from the FDA. It is based on pancrelipase (amylase;lipase;protease) (the active ingredients of Cotazym) and Cotazym (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ceftin and Sneezing - 4 seconds ago
- Pseudoephedrine Hydrochloride and Prilosec drug interaction - 5 seconds ago
- Zoledronic Acid and Lymphocyte Count Decreased - 7 seconds ago
- Sucralfate and Dutasteride drug interaction - 7 seconds ago
- Folvite and Arrhythmias - 8 seconds ago
- Allergic Rhinitis and Lung Infection - 10 seconds ago
- Depression and Camptodactyly Acquired - 15 seconds ago
- Oxycodone and Chronic Leukaemia - 16 seconds ago
- Prohance and Anaphylaxis - 18 seconds ago
- Monurol and Donepezil drug interaction - 19 seconds ago